Take, for example, the case of 2015. In this case, the . DOJ charged fourteen companies and individuals associated with with smuggling $78 million worth of mislabeled, unapproved and counterfeit cancer drugs into the . to sell to doctors. Of the fourteen defendants, only one was .-based. He appeared in court, entered into a deferred prosecution agreement, and the charges were dropped. . officials sought assistance through extradition treaties to detain the other thirteen defendants in their various foreign locations. The defendants remain at-large.